Home  >  News

Filter your search

Clear All Filters

Facebook Like Us Biosave Newsletter Signup Filter Biosave Filter Sale Labsave

News

Booming Breakthrough: Creative Biolabs Enables World’s First 100% Identification of Leucine and Isoleucine in De Novo Antibody Sequencing
Booming Breakthrough: Creative Biolabs Enables World’s First 100% Identification of Leucine and Isoleucine in De Novo Antibody Sequencing
Creative Biolabs
13/08/2019

It has long been a worldwide problem to precisely identify leucine and isoleucine, not to mention 100% accuracy. Creative Biolabs, the leader in De Novo antibody sequencing filed, never forgets to push the boundaries of science. They have successfully differentiated the sequences of leucine and isoleucine with 100% accuracy after overcoming challenges and difficulties. The amino acid sequence and specific post-translational modifications determine the specificities and...
Creative Biolabs’ DASS Has Unprecedentedly Accomplished 100% Accurate Distinction Between Leucine and Isoleucine
Creative Biolabs’ DASS Has Unprecedentedly Accomplished 100% Accurate Distinction Between Leucine and Isoleucine
Creative Biolabs
13/08/2019

With more than 25 years of experience as a CRO company, Creative Biolabs has recently made a tremendous breakthrough in the field of de novo monoclonal antibody sequencing with the Database Assisted Shotgun Sequencing (DASS) technology. The DASS is advanced from the Next Generation Sequencing (NGS) platform, which was used to sequence the variable regions, variable plus leader regions, as well as the full-length heavy and light-chain antibodies of all species, isotypes,...
Button_on Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave